内质网
肝细胞癌
癌症研究
未折叠蛋白反应
蛋白激酶B
化学
医学
药理学
细胞生物学
生物
信号转导
作者
Siqi Liao,Qingliang Wang,Siyuan Chen,Qixuan Huang,Li Zhou,Hongtao Liu,Song He,Zhihang Zhou
标识
DOI:10.1186/s12967-024-05545-5
摘要
Through high throughput screening, we identified that Mito-LND and (E)-Akt inhibitor-IV are two novel compounds against both parental and drug-resistant HCC cells, which could offer new strategies for HCC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI